Viewing Study NCT06333496



Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06333496
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-15
First Post: 2024-03-11

Brief Title: Effect of a Glucagon Like Peptide 1 GLP1 Booster in Healthy Humans
Sponsor: Alpine Biotech LLC
Organization: Alpine Biotech LLC

Study Overview

Official Title: Effect of a Glucagon Like Peptide 1 GLP1 Booster on Blood Glucose HbA1c Insulin and GLP1 Levels Body Weight and Body Fat in Overweight Adult Men and Women
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: BACKGROUND GLP1 booster GB was designed to stimulate the endogenous production of GLP1 which in turn releases insulin controls blood glucose level suppresses appetite and thus helps people lose weight

PURPOSE The purpose of this study is to assess several clinical endpoints and questionnaires in healthy volunteers taking the new GB formula

SCOPE The scope of this protocol covers the non-clinical portion as well as the assessment of several clinical endpoints and questionnaires In brief the non-clinical design will be an open-label study involving volunteers taking GB everyday for 12 weeks Data analysis will involve measuring the clinical endpoints across the group at different timepoints
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None